However, while TNFα blockade is a promising approach to prevent SLE-associated mandibular bone loss, anti-TNFα biologics are associated with serious toxicities, including a greatly increased risk of mycobacterial and other infections and a potential increased risk for lymphoma or skin cancer development17. This evidence concerns the gene TNF and infection.